Maslov_2022_Pharmaceuticals.(Basel)_15_273

Reference

Title : Design, Synthesis and Biological Evaluation of Neogliptin, a Novel 2-Azabicyclo[2.2.1]heptane-Based Inhibitor of Dipeptidyl Peptidase-4 (DPP-4) - Maslov_2022_Pharmaceuticals.(Basel)_15_273
Author(s) : Maslov IO , Zinevich TV , Kirichenko OG , Trukhan MV , Shorshnev SV , Tuaeva NO , Gureev MA , Dahlen AD , Porozov YB , Schioth HB , Trukhan VM
Ref : Pharmaceuticals (Basel) , 15 : , 2022
Abstract : Maslov_2022_Pharmaceuticals.(Basel)_15_273
ESTHER : Maslov_2022_Pharmaceuticals.(Basel)_15_273
PubMedSearch : Maslov_2022_Pharmaceuticals.(Basel)_15_273
PubMedID: 35337071

Related information

Citations formats

Maslov IO, Zinevich TV, Kirichenko OG, Trukhan MV, Shorshnev SV, Tuaeva NO, Gureev MA, Dahlen AD, Porozov YB, Schioth HB, Trukhan VM (2022)
Design, Synthesis and Biological Evaluation of Neogliptin, a Novel 2-Azabicyclo[2.2.1]heptane-Based Inhibitor of Dipeptidyl Peptidase-4 (DPP-4)
Pharmaceuticals (Basel) 15 :

Maslov IO, Zinevich TV, Kirichenko OG, Trukhan MV, Shorshnev SV, Tuaeva NO, Gureev MA, Dahlen AD, Porozov YB, Schioth HB, Trukhan VM (2022)
Pharmaceuticals (Basel) 15 :